AutoGen said this week that it has inked an agreement with Dubai's Gulf Scientific to distribute AutoGen's products in 12 countries in the Middle East.
AutoGen, based in Holliston, Mass., supplies the AutoGenFlex STAR system for DNA extraction from large volumes of whole blood for use in clinical and research institutions and biorepositories.
The company said that the deal aims to expand its presence in countries that are beginning to create biorepositories for DNA samples used in disease-related studies.
AutoGen launched the AutoGenFlex STAR system in December. The instrument includes a hand-held barcode scanner, a built-in centrifuge, robotic handling, and removable sample and DNA storage racks. AutoGen said that the system can isolate DNA from whole blood, buffy coats, tissues, cells, buccal swabs, Oragene saliva, and other sample types; and can generate DNA strands of up to 150 kilobases in length.
The platform relies on a protocol optimized for Qiagen’s FlexiGene whole-blood DNA extraction chemistry to isolate DNA from 40 blood samples of up to 10 milliliters each and produce 25 to 40 micrograms of DNA per milliliter.
AutoGen also has an agreement in place with Qiagen to be an authorized distributor of FlexiGene kits. AutoGen sells automated versions of the kit for use with the AutoGenFlex STAR; and sells the manual version of the kit for low-throughput manual applications.